ArticleDiscover oncology2025
Misdiagnosed follicular adenoma with 11 year postoperative liver and lung metastases a case report and literature review.
Article in Discover oncology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed, 1 synthesis or guideline pooled it.
- Molecular plasticity of LAMA3 across the disease spectrum: pathogenic mechanisms and clinical translation.Histochemistry and cell biology · 2026Pooled it
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundAs the second most common thyroid cancer, the follicular form has a good prognosis, but it is easily confused with follicular adenoma pre-operatively, which often leads to misdiagnosis, delayed treatment, and an increased risk of hematogenous metastasis. The optimization of diagnostic and treatment strategies is crucial for increasing the early diagnosis rate and improving the prognosis. CASE PRESENTATION: A 73-year-old male was misdiagnosed as "follicular adenoma" 11 years previously and the left thyroid adenoma was resected. He was admitted with a confirmed diagnosis of follicular thyroid cancer and multiple metastases to the liver and lungs. A total resection of the left residual thyroid and the right thyroid and isthmus was performed, combined with bilateral central lymph node dissection, and post-operatively, two 131I-NaI 100 mCi treatments for the metastatic foci in the liver and lungs were administered, as well as regularly receiving oral levothyroxine replacement therapy. The one-year follow-up showed no recurrence of the primary foci and a significant reduction in metastatic foci, confirming the effectiveness of the comprehensive treatment program.
conclusionPre-surgery, follicular thyroid carcinoma is easily confused with follicular adenoma and nodular goiter with non-invasive encapsulated follicular tumors with papillary carcinoma nuclei, and it requires standardized treatment and detection of metastatic foci. Surgery combined with radioiodine is the mainstay of treatment and it is supplemented with levothyroxine replacement therapy. Targeted drugs are available for patients, refractory to radiotherapy. Long-term follow-up is essential to improve the prognosis.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.